Citius Pharmaceuticals, Inc. (CTXR) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$25.6K2012: -$1.02M2013: -$1.18M2014: -$653.8K2015: -$3.23M2016: -$7.45M2017: -$9.99M2018: -$13.79M2019: -$15.60M2020: -$17.71M2021: -$23.53M2022: -$33.32M2023: -$36.73M2024: -$42.00M2025: -$38.53M-$38.53M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$38.53M+8.3%
2024-$42.00M-14.3%
2023-$36.73M-10.3%
2022-$33.32M-41.6%
2021-$23.53M-32.9%
2020-$17.71M-13.5%
2019-$15.60M-13.1%
2018-$13.79M-38.1%
2017-$9.99M-34.1%
2016-$7.45M-130.6%
2015-$3.23M-394.0%
2014-$653.8K+44.7%
2013-$1.18M-16.4%
2012-$1.02M-3863.5%
2011-$25.6K